As also NFATC1 promotes motility of prostate cancer cells and as PIM-selective inhibitors can block this [4], we now wanted to investigate whether or not PIM-dependent phosphorylation of NFATC1 is important for migration and invasion of prostate cancer cells. This evidence concerns the gene NFATC1 and prostate carcinoma.